Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1166 results found. Search for [ pharmaceutical companies ]

Results 1000 to 1020 of 1166
Suman Layak and Rajiv Bhuva
May 1, 2012
Subex, Cranes Software, Strides Arcolab, GTL Infrastructure, Indowind Energy and Suzlon Energy are just a few names among the Indian mid-sized companies on the long list of FCCB borrowers facing headwinds.


BT Online Bureau
New Delhi, April 18, 2012
US Supreme Court has ruled in favour of the company's subsidiary, Caraco Pharmaceutical Laboratories, in it's patent litigation against Novo Nordisk.


BT Online Bureau
New Delhi, April 9, 2012
The tablets are generic version of Janssen Pharmaceuticals Inc oral contraceptive Ortho Cyclen tablets.


Mail Today Bureau
New Delhi, April 5, 2012
A survey says 84 per cent of Indian companies are currently looking to push up recruitment while only 16 per cent are contemplating to maintain the same level of headcount.


Shweta Punj
April 11, 2012
Business confidence, which had just begun to recover, took a fresh hit with the unveiling of Budget 2012/13, as corporate houses grappled with the uncertainty and the impact of the new tax policies, says Business Today-C fore's latest survey.


www.businesstoday.in
March 29, 2012
Business Today's E Kumar Sharma talks about the challenges facing the increasingly competitive pharmaceutical industry, and what compulsory licensing can and can't do for India's poor.


Dinesh C. Sharma
New Delhi, March 28, 2012
The landmark decision of the patent office to break the monopoly of Bayer in kidney and liver cancer drugs recently is already having a rippling effect.


Tanvi Varma & Sowmya Kamath
May 10, 2012
Budget 2012 - Individuals get incentives to invest in stocks; mixed bag for industry.


E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?


Tanvi Varma
March 22, 2012
As the economy recovers, so will small-cap and mid-cap stocks. It may be the right time to invest in them.


Manasi Mithel
March 19, 2012
Home to the highest concentration of makers of generic drugs, India has been a global source of cheap medicines. But seven years into the product patent regime, affordable access to some lifesaving drugs remains an issue.


Rahul Oberoi/Money Today
March 27, 2012
Are stock markets sensing better days ahead for India Inc? Third quarter results showed India Inc in better shape than expected. The next quarter may bring positive surprises.


Tanvi Varma/Money Today
March 2, 2012
The worst seems over for stocks of small-cap and mid-cap companies, which had to bear most of the brunt of the market slowdown last year. It may be the right time to invest.


E Kumar Sharma
February 22, 2012
Despite fiscal compulsions, the finance minister could attend to some long-pending demands of the sector, hopes the healthcare and pharma sector.


PTI
New Delhi, February 21, 2012
Employees in India seem to have a reason to cheer despite the prevailing economic uncertainties, as they could get pay hikes of as much as 20 per cent this year, as per two different salary surveys released on Tuesday.


Rahul Oberoi/Money Today
February 3, 2012
Here's how shares in rupee-sensitive sectors are likely to perform.


Geetanjali Shukla
January 9, 2012
Though they compete fiercely, Lupin Pharmaceuticals, Aurobindo Pharma, Zydus Cadila, Orchid Chemicals and Pharmaceuticals and Ranbaxy - each one a giant - came together in July 2010 to share their best practices, in a bid to improve efficiency and bring down rising operating costs.


Sowmya Kamath
January 2, 2012
We explore stocks and sectors that have limiteddownside for those who wish to be safe and yet do not want to miss the bus incase the markets rise in 2012.


PTI
New Delhi, December 9, 2011
Under the new rules, for any merger or acquisition, theoverseas investor will have to seek permission from the Foreign Investment Promotion Board (FIPB).


Rajiv Bhuva
December 14, 2011
Oil, metals and mining companies will be the biggest losers as imports will become costlier, while companies in the pharmaceutical and IT sectors stand to gain.


PAGES 51 OF 59  5152535455